Tortuga Wealth Management
ABBV icon

Tortuga Wealth Management’s AbbVie ABBV Stock Holding History

Tortuga Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.04M Sell
3,972
-161
-4% -$41.3K 0.74% 34
2026
Q2 		$1.04M Buy
4,133
+612
+17% +$132K 0.79% 33
2026
Q1 		$766K Buy
3,521
+249
+8% +$55.2K 0.72% 34
2025
Q4 		$748K Buy
+3,272
New +$745K 0.79% 29

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Tortuga Wealth Management's ABBV Position: Q3 2026 in Review

Tortuga Wealth Management reduced its AbbVie (ABBV) stake by 3.9% in Q3 2026, selling an estimated $41.3K and leaving 3,972 shares worth $1.04M. The position accounts for 0.74% of the portfolio, ranked #34.

Tortuga Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.04M in Q2 2026. 1,792 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Tortuga Wealth Management held 3,972 shares of AbbVie worth $1.04M as of Q3 2026.
  • Tortuga Wealth Management sold 161 AbbVie shares in Q3 2026, an estimated $41.3K.
  • AbbVie made up 0.74% of Tortuga Wealth Management's portfolio in Q3 2026, its #34 holding.
  • Tortuga Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Tortuga Wealth Management's AbbVie position peaked at $1.04M in Q2 2026.
  • 1,792 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Tortuga Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.